These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36446430)

  • 1. Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease.
    Floyd L; Bate S; Hadi Kafagi A; Brown N; Scott J; Srikantharajah M; Myslivecek M; Reid G; Aqeel F; Frausova D; Kollar M; Kieu PL; Khurshid B; Pusey CD; Dhaygude A; Tesar V; McAdoo S; Little MA; Geetha D; Brix SR
    J Am Soc Nephrol; 2023 Mar; 34(3):505-514. PubMed ID: 36446430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
    van Daalen EE; Jennette JC; McAdoo SP; Pusey CD; Alba MA; Poulton CJ; Wolterbeek R; Nguyen TQ; Goldschmeding R; Alchi B; Griffiths M; de Zoysa JR; Vincent B; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):63-72. PubMed ID: 29162595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Risk Prediction Models in Predicting Kidney Outcomes in Antiglomerular Basement Membrane Disease.
    Kuang H; Zhao YY; Wang JW; Cui Z; Zhao MH; Jia XY
    Kidney Int Rep; 2024 Mar; 9(3):624-634. PubMed ID: 38481502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
    Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
    Front Immunol; 2022; 13():991469. PubMed ID: 36389826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
    Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
    Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.
    Alchi B; Griffiths M; Sivalingam M; Jayne D; Farrington K
    Nephrol Dial Transplant; 2015 May; 30(5):814-21. PubMed ID: 25609740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.
    McAdoo SP; Tanna A; Hrušková Z; Holm L; Weiner M; Arulkumaran N; Kang A; Satrapová V; Levy J; Ohlsson S; Tesar V; Segelmark M; Pusey CD
    Kidney Int; 2017 Sep; 92(3):693-702. PubMed ID: 28506760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.
    Zahir Z; Wani AS; Prasad N; Jain M
    Ren Fail; 2021 Dec; 43(1):79-89. PubMed ID: 33334228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
    Zhao M; Ding J; Liu Y; Zou W; Wang H
    Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Tennstedt P; Vettorazzi E; Busch M; Nitschke M; Jabs WJ; Özcan F; Wendt R; Hausberg M; Sellin L; Panzer U; Huber TB; Waldherr R; Hopfer H; Stahl RAK; Wiech T
    Kidney Int; 2018 Dec; 94(6):1177-1188. PubMed ID: 30385041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Goodpasture's disease: a report of ten cases and a review of the literature.
    Dammacco F; Battaglia S; Gesualdo L; Racanelli V
    Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report.
    Shibata Y; Fukuoka K; Yokota R; Lee H; Sayo H; Ikegaya N; Mori K; Yamamoto J; Isomura A; Nagahama K; Shimoyamada H; Kawakami T; Komagata Y; Kaname S
    BMC Nephrol; 2020 Jul; 21(1):283. PubMed ID: 32680573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials.
    Bate S; McGovern D; Costigliolo F; Tan PG; Kratky V; Scott J; Chapman GB; Brown N; Floyd L; Brilland B; Martín-Nares E; Aydın MF; Ilyas D; Butt A; Nic An Riogh E; Kollar M; Lees JS; Yildiz A; Hinojosa-Azaola A; Dhaygude A; Roberts SA; Rosenberg A; Wiech T; Pusey CD; Jones RB; Jayne DRW; Bajema I; Jennette JC; Stevens KI; Augusto JF; Mejía-Vilet JM; Dhaun N; McAdoo SP; Tesar V; Little MA; Geetha D; Brix SR
    J Am Soc Nephrol; 2024 Mar; 35(3):335-346. PubMed ID: 38082490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Glomerular Basement Membrane Disease.
    McAdoo SP; Pusey CD
    Clin J Am Soc Nephrol; 2017 Jul; 12(7):1162-1172. PubMed ID: 28515156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-glomerular basement membrane vasculitis.
    Ponticelli C; Calatroni M; Moroni G
    Autoimmun Rev; 2023 Jan; 22(1):103212. PubMed ID: 36252931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series.
    Ahmad SB; Santoriello D; Canetta P; Bomback AS; D'Agati VD; Markowitz G; Ahn W; Radhakrishnan J; Appel GB
    Am J Kidney Dis; 2021 Aug; 78(2):219-225.e1. PubMed ID: 33421452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
    Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
    Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort.
    Shen CR; Jia XY; Cui Z; Yu XJ; Zhao MH
    Front Immunol; 2020; 11():2035. PubMed ID: 33013861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.